NCT06573281 A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06572384 A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease Status RECRUITING Phase PHASE3
NCT06567782 A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer Status RECRUITING Phase PHASE2
NCT06551181 A Study on the Immune Response, Safety and the Occurrence of Respiratory Syncytial Virus (RSV)-Associated Respiratory Tract Illness After Administration of RSV OA Vaccine in Adults 60 Years and Older Status COMPLETED Phase PHASE3
NCT06551142 A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD) Status RECRUITING Phase PHASE1
NCT06537414 A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06534892 An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06533813 Clinical Epidemiology in Contemporary Patients With Myelofibrosis. Status RECRUITING Phase N/A
NCT06527872 Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN Status RECRUITING Phase N/A
NCT06521567 A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06517875 Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis Status RECRUITING Phase PHASE2
NCT06506266 Study of the Effect of HFA-152a and HFA-134a Propellants on Mucociliary Clearance in Healthy Participants Status COMPLETED Phase PHASE1
NCT06497504 Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06489964 Addressing Unfunded Vaccines Through a Co-payment Mechanism in Pharmacies Status RECRUITING Phase NA
NCT06488703 Retrospective Analysis of Systemic Glucocorticoid Mediated Long-term Effects, Patient Pathways and Economic Burden Across Multiple Indications Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06472076 A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06468995 Antiviral Long Acting Drugs Landing in People Living With HIV Status ACTIVE_NOT_RECRUITING Phase NA
NCT06447506 Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis. Status TERMINATED Phase PHASE2
NCT06433921 A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive Status RECRUITING Phase PHASE1
NCT06433908 A Study to Compare the Pharmacokinetics (PK) of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152A (Test) or HFA-134A (Reference) in Healthy Participants Aged 18 to 55 Inclusive Status COMPLETED Phase PHASE1